Literature DB >> 11137648

Ceftibuten stability to active-site serine and metallo-beta-lactamases.

M Perilli1, B Segatore, N Franceschini, G Gizzi, A Mancinelli, B Caravelli, D Setacci, M M del Tavio-Perez, B Bianchi, G Amicosante.   

Abstract

Ceftibuten is an oral third-generation cephalosporin active against a wide range of bacteria and shows an improved stability to hydrolysis by several beta-lactamases because of the carboxyethilidine moiety at position 7 of the ss-acyl side chain. The kinetic interactions between ceftibuten and active-site serine and metallo-ss-lactamases were investigated. The activity of several TEM-derived extended spectrum beta-lactamases (ESbetaLs) against ceftibuten, cefotaxime and ceftazidime was compared using K(m), K(cat) and K(cat)/K(m). Ceftibuten behaved as a poor substrate for class A and B beta-lactamases compared with cefotaxime. The chromosomal class C beta-lactamase from Enterobacter cloacae 908R gave a high K(cat) value (21 s(-1)), whereas there was poor activity with enzymes from Acinetobacter baumannii and Morganella morganii and ceftibuten. Ceftibuten resists hydrolysis in the presence of typical respiratory or urogenital-tract pathogens producing beta-lactamases.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11137648     DOI: 10.1016/s0924-8579(00)00319-8

Source DB:  PubMed          Journal:  Int J Antimicrob Agents        ISSN: 0924-8579            Impact factor:   5.283


  2 in total

1.  Ceftibuten plus amoxicillin-clavulanic acid for oral treatment of urinary tract infections with ESBL producing E. coli and K. pneumoniae: a retrospective observational case-series.

Authors:  James Cohen Stuart; Maurine Leverstein-Van Hall; Willemijn Kortmann; J Verlind; Frouke Mulder; Jelle Scharringa; Ad Fluit; Miquel Ekkelenkamp
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2018-08-16       Impact factor: 3.267

2.  In Vivo Pharmacodynamic Profile of Ceftibuten-Clavulanate Combination against Extended-Spectrum-β-Lactamase-Producing Enterobacteriaceae in the Murine Thigh Infection Model.

Authors:  Kamilia Abdelraouf; Sean M Stainton; David P Nicolau
Journal:  Antimicrob Agents Chemother       Date:  2019-06-24       Impact factor: 5.191

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.